Topological descriptors in modeling tumor necrosis factor alpha inhibitory activity of xanthines, pteridinediones and related compounds

Internet Electronic Journal of Molecular Design

Volumn 6, Issue 8, 2007, Pages 218-228

  Jain, Hemant Kumar ^a,b   Agrawal, Ram Kishore ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b Nri Institute Of Pharamcy Bhopal   (India)

Author keywords

Pteridinediones; QSAR; TNF alpha inhibitor; Topological indices; Tumor necrosis factor alpha; Xanthines

Indexed keywords

EID: 34848830691     PISSN: None     EISSN: 15386414     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. J. Vilcek, and T. H. Lee, Tumor Necrosis Factor, new insights into the molecular mechanisms of its multiple action, J. Biol. Chem. 1991, 266, 7313-7316.
2. R. M. Locksley, N. Killeen, and M. J. Lenardo, The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology, Cell 2001, 104, 487-501.
3. K. J. Tarcey, The inflammatory reflex, Nature, 2002, 420, 853-859.
4. J. F. Cheng, M. Chen, D. Wallace, S. Tith,; T. Arrhenius, H. Kashiwagi, Y. Ono, A. Ishikawa, H. Sato, T. Kozono, H. Sato, and A.M. Nadzan, Discovery and structure-activity relationship of coumarin derivatives as TNF-α inhibitors Bioorg. Med. Chem. Lett. 2004, 14, 2411-2515.
5. H. M. Van Dulleman, S. J. H. Van Deventer, D. W. Hommes, H. A. Bijl, J. Jansen, G. N. Tytget, and J. Woody, Treatment of Crohn's Disease with Antitumor Necrosis Factor Chimeric Monoclonal Antibody (cA2), Gastroenterology 1995, 109, 129-135.
6. S. Miwatashi, Y. Arikawa, E. Kotani, M. Miyamoto, K. Naruo, H. Kimura, T. Tanaka, S. Asahi, and S. Ohkawa, Novel Inhibitor of p38 MAP Kinase as an Anti-TNF-α Drug: Discovery of N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3- thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a Potent and Orally Active Anti-Rheumatoid Arthritis Agent J. Med. Chem. 2005, 48, 5966-5979.
7. L. Kincaid, Psoriasis:TNF-α inhibitors and beyond, Drug Discov. Today 2005, 10, 884-886.
8. D. A. van Heel, I. A. Udalova, A. P. De Silva, D. P. McGovern, Y. Kinouchi, J. Hull, N. J. Lench, L. R. Cardon, A. H. Carey, D. P. Jewell and D. Kwiatkowski, Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-B transcription factors, Human Molecular Genetics, 2002, 11, 1281-1289.
9. M. J. Elliott, R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Leeb, F. C. Breedveld, J. D. Macfarlane, H. Bijl, and J. N. Woody, Randomised Double-Blind Comparison of Chimeric Monoclonal Antibody to Tumour Necrosis Factor R (cA2) versus Placebo in Rheumatoid Arthritis. Lancet 1994, 344, 1105-1110.
10. L. W. Moreland, S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler, M. B. Widmer, and C. M. Blosch, Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)-Fc Fusion Protein, N. Engl. J. Med. 1997, 337, 141-147.
11. B. Bresnihan, The Prospect of Treating Rheumatoid Arthritis with Recombinant Human Interleukin-1 Receptor Antagonist, BioDrugs BioDrugs 2001, 15, 87-97.
12. M. Vracko and J. Gasteiger, A. QSAR Study on a Set of 105 Flavonoid Derivatives Using Descriptors Derived From 3D Structures, Internet Electron. J. Mol. Des. 2002, 1, 527-544, http://www.biochempress.com.
13. A. V. Raichurkar and V. M. Kulkarni, 3D-QSAR of Cyclooxygenase-2 Inhibitors by Genetic Function Approximation, Internet Electron. J. Mol. Des. 2003, 2, 242-261, http://www.biochempress.com.
14. S. M. Vadlamudi and V. M. Kulkarni, 3D-QSAR of Protein Tyrosine Phosphatase 1B Inhibitors by Genetic Function Approximation, Internet Electron. J. Mol. Des. 2004, 3, 586-609, http://www. biochempress.com.
15. H. B. Cottam, H. Shih, L. R. Tehrani, D. B. Wasson, and D. A. Carson, Substituted xanthines, pteridinediones, and related compounds as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha, J. Med. Chem. 1996, 39, 02-09.
16. CS Chem Office, Version 6.0, Cambridge Soft Corporation, Washington D.C. USA.
17. DRAGON Software (Version 3.0 - 2003), by R. Todeschini, V. Consonni, A. Mauri and M. Pawan, Milano Chemometrics, Italy.
18. L. B. Kier, Molecular Orbital Theory in Drug Research, Academic Press, New York, 1971, pp 1-62.
19. H. K. Jain and R. K. Agrawal, QSAR analysis of indomethacin derivatives as selective COX-2 inhibitors, Internet Electron. J. Mol. Des. 2006, 5, 224-236, http://www.biochempress.com.
20. H. K. Jain and R. K. Agrawal, Inhibitory mode of 2-acetoxyphenyl alkyl sulfides against COX-1 and COX-2: QSAR analyses, Bioorg. Med. Chem. Lett. 2006, 16, 5280-5284.
21. R. Todeschini and V. Consonni, Handbook of molecular descriptors, Wiley-VCH Verlag GmbH, Weinheim, Germany.
22. SYSTAT, Instruction Manual, University of Waterloo, Department of Statistics and Actuarial Science, September 1, 1998.
23. A. K. Gupta, M. A. Babu and S. G. Kaskhedikar, VALSTAT: Validation program for Quantitative Structure Activity Relationships Studies, Indian J. Pharm. Sci. 2004, 66, 396-402.
24. M. K. Gupta and Y. S. Prabhakar, Topological descriptors in modeling the antimalarial activity of 4-(3′,53′-disubstituted anilino)quinolines, J. Chem. Inf. Model. 2006, 46, 93-102.